A comparison of the oleaginous yeast,Candida curvata, grown on different carbon sources in continuous and batch culture

Lipids ◽  
1983 ◽  
Vol 18 (9) ◽  
pp. 623-629 ◽  
Author(s):  
Christopher T. Evans ◽  
Colin Ratledge
2011 ◽  
Vol 35 (5) ◽  
pp. 1906-1911 ◽  
Author(s):  
Jie Zhang ◽  
Xu Fang ◽  
Xiao-Ling Zhu ◽  
Yan Li ◽  
Hai-Peng Xu ◽  
...  

BioResources ◽  
2014 ◽  
Vol 9 (4) ◽  
Author(s):  
Ruling Wang ◽  
Jiancai Wang ◽  
Ronghua Xu ◽  
Zhen Fang ◽  
Aizhong Liu

2020 ◽  
Vol 315 ◽  
pp. 123897
Author(s):  
Mou Tang ◽  
Yanan Wang ◽  
Wenting Zhou ◽  
Mian Yang ◽  
Yi Liu ◽  
...  

2016 ◽  
Vol 4 (6) ◽  
Author(s):  
Dan Close ◽  
John Ojumu

Cryptococcus curvatus ATCC 20509 is a commonly used nonmodel oleaginous yeast capable of converting a variety of carbon sources into fatty acids. Here, we present the draft genome sequence of this popular organism to provide a means for more in-depth studies of its fatty acid production potential.


2012 ◽  
Vol 33 (1) ◽  
pp. 71-84 ◽  
Author(s):  
Marta Pawlak ◽  
Marcin Bizukojć ◽  
Stanisław Ledakowicz

Impact of bioreactor scale on lovastatin biosynthesis by Aspergillus terreus ATCC 20542 in a batch culture Biosynthesis of lovastatin (a polyketide metabolite of Aspergillus terreus) in bioreactors of different working volume was studied to indicate how the change of scale of the process influences the formation of this metabolite. The experiments conducted in shake flasks of 150 ml working volume allowed to obtain lovastatin titres at the level of 87.5 mg LOV l-1, when two carbon sources, namely lactose and glycerol were used. The application of the same components in a large stirred-tank bioreactor of 5.3-litre working volume caused a decrease of lovastatin production by 87% compared to the shake flask culture. The deficiency of nitrogen in this bioreactor did not favour the formation of lovastatin, in contrast to the small bioreactor of 1.95-litre working volume, in which lovastatin titres comparable to those in the shake flasks could be achieved, when organic nitrogen concentration was two-fold decreased. When the control of pH and/or pO2 was used simultaneously, an increase in lovastatin production was observed in the bioreactors. However, these results were still slightly lower than lovastatin titres obtained in the shake flasks.


Sign in / Sign up

Export Citation Format

Share Document